Sanofi-Aventis (France) Fails to Block Sale of Generic Cancer Drug Taxotere in Australia

February 2, 2011 |

1 min read

Bloomberg -- Sanofi-Aventis SA failed to block two generic drug manufacturers from selling a copy of the cancer drug Taxotere in Australia, with a federal court judge refusing to bar the sale of the generics.

Legal

Sanofi

MORE ON THIS TOPIC

Approved and confirmed document file with check mark icon flat cartoon, concept of agreement or contract symbol with checkmark, accepted or certified license paper form pictogram isolated image

Manufacturing

Eli Lilly and Regeneron among 7 companies picked for FDA PreCheck pilot program

July 1, 2026

·

2 min read

·

Nick Paul Taylor

Plan to buying new house or renovation, mortgage loan or housing expense, property maintenance or real estate insurance concept, smart businessman put jigsaw to complete or finishing house puzzle.

FDA

BIO 2026: FDA’s IND initiative is a step toward normalization after slipshod year

June 25, 2026

·

3 min read

·

Isometric arrow overcoming above wall on turquoise blue background. Challenge, success, development and solution concept. Flat design. Vector illustration, no transparency, no gradients

Duchenne muscular dystrophy

REGENXBIO bets on FDA flexibility with filing plans for Duchenne gene therapy

June 24, 2026

·

2 min read

·

Gabrielle Masson

From left to right: Julie Tierney, former deputy director of the FDA’s Center for Biologics Evaluation and Research (CBER); Ian Simon, former lead of HHS’ Office of Long Covid; Demetre Daskalakis, former director of the CDC’s National Center for Immunization and Respiratory Diseases; Jennifer Eileen Towne, chief scientific officer at Vir Biotechnology; Jared Bauer, CEO and cofounder of Seek Labs

Policy

BIO 2026: US public health as we know it is gone. Can we rebuild a better system?

June 23, 2026

·

4 min read

·